Answers are grounded in this paper and cite their sources.
Background Peritoneal dissemination represents the most lethal form of metastasis in gastric cancer (GC), driven by epithelial–mesenchymal transition (EMT) and immune suppression within the tumor microenvironment. The vitamin D receptor (VDR) is a nuclear transcription factor that maintains epithelial integrity and immune homeostasis, yet its activity is frequently diminished in advanced GC. Analysis of clinical gastric cancer specimens revealed reduced VDR expression associated with metastatic progression and EMT-related phenotypes. This study investigated whether honokiol (HK), a natural biphenolic compound derived from Magnolia officinalis, suppressed gastric cancer metastasis through direct interaction with VDR and activation of VDR-dependent signaling. Methods Human GC cell lines, clinical GC specimens, macrophage co-culture systems, and VDR-silenced or site-mutated cells were used to evaluate the effects of honokiol on VDR signaling. Direct interaction between honokiol and VDR was examined using ligand-binding assays, differential scanning calorimetry (DSC), and molecular docking analysis to identify potential binding sites within the VDR ligand-binding domain. VDR phosphorylation and nuclear localization were assessed by immunoblotting and immunofluorescence. EMT-related transcriptional regulation was evaluated using electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (ChIP). Macrophage polarization and tumor–macrophage interactions were analyzed using live-cell confocal microscopy. Antimetastatic activity was further validated in a nude mouse peritoneal dissemination model using positron emission tomography/computed tomography (PET/CT) imaging and histopathological examination. Results Clinical GC samples showed significantly reduced VDR expression in metastatic lesions and were associated with EMT-related markers. Binding assays and DSC analysis demonstrated a direct interaction between honokiol and VDR, while molecular docking predicted stable binding of honokiol within the VDR ligand-binding pocket. Honokiol induced phosphorylation of VDR at the Ser208 site, promoting its nuclear translocation and transcriptional activity. Activation of VDR suppressed Twist transcription, thereby inhibiting EMT and reducing tumor invasiveness. In addition, VDR activation reprogrammed tumor-associated macrophages (TAMs) from an immunosuppressive M2 phenotype to an antitumor M1 phenotype, enhancing macrophage recruitment and phagocytic activity. In vivo, honokiol markedly reduced peritoneal tumor burden and metabolic activity in the dissemination model, whereas these antimetastatic effects were abolished by VDR silencing or mutation of the Ser208 phosphorylation site. Conclusions Honokiol directly binds to VDR and activates VDR signaling through phosphorylation at the Ser208 site , leading to suppression of EMT and reprogramming of tumor-associated macrophages. The honokiol–VDR–Twist signaling axis represents a mechanistically defined therapeutic pathway for inhibiting GC peritoneal dissemination and restoring immune homeostasis.
No takes yet. Share an insight, caveat, or question.
Pan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: